Which risk factors causally influence dementia? A systematic review of Mendelian randomization studies

Manuscript Number: 

18-0013R1

Author(s): 
Alison Bethel, Eilis Hannon, Elina Hyppönen, Elżbieta Kuźma, Deborah A. Levine, David J. Llewellyn, Ilianna Lourida, Katie Lunnon, Jo Thompson-Coon, Ang Zhou

Disclosures

Alison Bethel

  • Nothing to Disclose

Eilis Hannon

  • Nothing to Disclose

Elina Hyppönen

  • Nothing to Disclose

Elżbieta Kuźma

  • Nothing to Disclose

Deborah A. Levine

  • Consulting Fees:
    Consultant, Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial, a Randomized, Double-blind, Multi-center Clinical Trial. (NINDS 1U01S062835-01A1; Johnston SC/Easton JD, Multiple PIs; 09/01/2009-06/30/2016), Event Adjudicator.

David J. Llewellyn

  • Nothing to Disclose

Ilianna Lourida

  • Nothing to Disclose

Katie Lunnon

  • Nothing to Disclose

Jo Thompson-Coon

  • Nothing to Disclose

Ang Zhou

  • Nothing to Disclose